Atlas Trials

Biohaven Pharmaceuticals, Inc.

15 clinical trials · Sponsor

Sort:Newest firstOldest first

◉ Watch Biohaven Pharmaceuticals, Inc.

RecordFirmDate
A Study to Evaluate the Efficacy and Safety of Taldefgrobep Alfa in Participants With Spinal Muscular Atrophy (NCT05337553)Biohaven Pharmaceuticals, Inc.2022-07-06
Autologous Memory-like NK Cell Therapy With BHV-1100 and Low Dose IL-2 in Multiple Myeloma Patients (NCT04634435)Biohaven Pharmaceuticals, Inc.2021-10-21
Long-term Safety Study of Adjunctive Troriluzole in Subjects With Obsessive Compulsive Disorder (NCT04708834)Biohaven Pharmaceuticals, Inc.2021-03-30
A Study to Evaluate the Efficacy and Safety of Adjunctive Troriluzole in Obsessive-Compulsive Disorder (NCT04693351)Biohaven Pharmaceuticals, Inc.2021-01-29
Efficacy and Safety Study of Adjunctive Troriluzole in Obsessive Compulsive Disorder (NCT04641143)Biohaven Pharmaceuticals, Inc.2020-12-22
Troriluzole in Adult Participants With Spinocerebellar Ataxia (NCT03701399)Biohaven Pharmaceuticals, Inc.2019-03-08
Randomized Trial of Adult Participants With Generalized Anxiety Disorder (NCT03829241)Biohaven Pharmaceuticals, Inc.2019-02-19
Open-label Study to Evaluate Safety, Tolerability and PK of BHV-0223 in ALS (NCT03520517)Biohaven Pharmaceuticals, Inc.2018-02-02
Troriluzole (BHV-4157) in Adult Participants With Obsessive Compulsive Disorder (NCT03299166)Biohaven Pharmaceuticals, Inc.2017-12-19

Track Biohaven Pharmaceuticals, Inc. automatically

Every clearance here is in the API, with alerts when new ones post.